International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma
Step into the forefront of myeloma treatment with this latest publication from the International Myeloma Working Group immunotherapy committee. Discover the groundbreaking world of immunotherapy, where innovations like CAR T-cell therapy and bispecific antibodies are reshaping myeloma treatment. An expert panel provides exclusive insights and tailored recommendations, guiding the way to optimised patient care. Ready…